MARKETSSakar Healthcare Shares Rally 4% on 9 Cancer Drug ApprovalsΒ Ali WaghbakriwalaNovember 7, 2025November 7, 2025 November 7, 2025November 7, 2025 Shares of Sakar Healthcare Ltd rallied 4% on Friday, 7 November, after the company announced securing marketing approval for 9 drugs. In its regulatory filing,...
Latest NewsFDA has increased its fees for drug approvals, reduces unit inspection chargeadminAugust 5, 2015 August 5, 2015 The US regulator FDAhas increased its fees for new generic drug applications by up to 30 percent and the fees for facility inspection of foreign...